Status:
COMPLETED
Non-invasive Spinal Cord Stimulation for Spasticity Control and Augmentation of Voluntary Motor Control in Individuals With Multiple Sclerosis
Lead Sponsor:
Medical University of Vienna
Collaborating Sponsors:
Neurological Center, Otto Wagner Hospital
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-80 years
Phase:
EARLY_PHASE1
Brief Summary
Epidural spinal cord stimulation (SCS) is currently regarded as one of the most promising intervention methods to improve motor function in individuals with severe spinal cord injury. In parallel, an ...
Eligibility Criteria
Inclusion
- confirmed diagnosis of relapsing-remitting, primary- or secondary-progressive MS
- lower-limb spasticity
Exclusion
- acute relapse of MS
- other neuromuscular diseases
- active and passive implants at vertebral level T9 or caudally
- dermatological issues at stimulation site
- pregnancy
Key Trial Info
Start Date :
December 27 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2020
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04486209
Start Date
December 27 2017
End Date
July 2 2020
Last Update
October 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Austria, 1090